According to its website, the U.S. Food and Drug Administration has granted tentative approval for Indian generic pharmaceutical company Strides Acrolan Ltd.’s new fixed-dose combination antiretroviral therapy, Reuters reports (malaysia.news.yahoo.com, 3/26).
According to the article, the drug contains lamivudine, stavudine and nevirapine. Its tentative approval means that while the drug cannot be marketed in the U.S. due to patent laws and other issues, it can be considered for the President’s Emergency Plan for AIDS Relief (PEPFAR), which provides HIV medications to developing countries.
NEW! Scroll down to comment on this story.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
"I'm HIV positive and diabetic (as well as have high cholesterol) and some of my meds specify taking them with 'high fat foods' which I have to do twice a day. I've eaten as healthy as possible, but when it comes to high fat foods, I am in a quandary...about what to eat sometimes..."
